Structure Therapeutics Inc.
GPCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001888886
No open-market purchases or sales by Structure Therapeutics Inc. insiders were filed in the last 90 days; 191 institutions reported holding it in 13F filings for Q2 2026, worth $3.62B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Structure Therapeutics Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 191
- −5 vs. Q1 2026
- Shares held
- 67.6M
- +6.08M (+9.9%) vs. Q1 2026
- Total value
- $3.62B
- +$653.6M (+22.0%) vs. Q1 2026
- New holders
- 27
- 75 more added
- Sold out
- 32
- 53 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GPCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 191 | $3.62B |
| Q1 2026 | 198 | $3.23B |
| Q4 2025 | 199 | $4.58B |
| Q3 2025 | 158 | $1.59B |
| Q2 2025 | 173 | $1.14B |
| Q1 2025 | 151 | $990.0M |
| Q4 2024 | 165 | $1.65B |
| Q3 2024 | 161 | $2.69B |
| Q2 2024 | 167 | $2.33B |
| Q1 2024 | 119 | $1.86B |
| Q4 2023 | 122 | $1.74B |
| Q3 2023 | 84 | $1.64B |
| Q2 2023 | 48 | $699.4M |
| Q1 2023 | 38 | $346.2M |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Structure Therapeutics Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −55,800−100.0% | Sold out |
| Monashee Investment Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Pier Capital, LLC | 0 | $0 | 0.00% | −47,551−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −37,156−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −30,921−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −21,360−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −18,263−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −14,814−100.0% | Sold out |
| Russell Investments Group, Ltd. | 0 | $0 | 0.00% | −10,701−100.0% | Sold out |
| Axq Capital, LP | 0 | $0 | 0.00% | −7,916−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −6,958−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −5,879−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −5,772−100.0% | Sold out |
| Toroso Investments, LLC | 0 | $0 | 0.00% | −4,643−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,738−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −558−100.0% | Sold out |
| SOA Wealth Advisors, LLC. | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| Farmers & Merchants Investments Inc | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Basecamp Wealth Advisors LLC | 0 | $0 | 0.00% | −84−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Ancora Advisors, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| IMA Wealth, Inc. | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |